Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. 1986

C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori

The proliferative response of peripheral blood T cells to hepatitis B surface antigen (HBsAg), pre-S antigen and hepatitis B core antigen (HBcAg) has been studied in 20 patients with hepatitis B virus induced chronic active hepatitis (CAH) and in 12 control subjects. Eleven of the 20 CAH patients showed a significant T lymphocyte proliferative response to HBcAg, whereas no proliferation was detectable in response to envelope antigens (HBs and pre-S) in any patient. T cell subset fractionation revealed that HBcAg specific proliferation was limited to the CD4+ (helper/inducer) population. CD8+ (suppressor/cytotoxic) T cells were unresponsive to HBcAg and did not suppress the proliferative response of autologous CD4+ cells. The HBcAg specific T cell proliferative response did not correlate with serum anti-core antibody titres or with biochemical evidence of liver disease. The present results show the selective presence of HBcAg-sensitized T cells in the peripheral blood of patients with HBsAg positive CAH and suggest that the peripheral lymphoid compartment may not reflect immunopathogenetically important cellular events operative at the site of tissue injury.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006512 Hepatitis B Core Antigens The hepatitis B antigen within the core of the Dane particle, the infectious hepatitis virion. HBcAg,Hepatitis B Core Antigen
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral

Related Publications

C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori
November 1994, Immunopharmacology and immunotoxicology,
C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori
August 1980, Digestive diseases and sciences,
C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori
February 1978, British medical journal,
C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori
August 1985, Gastroenterology,
C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori
October 1977, Clinical and experimental immunology,
C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori
January 1992, Digestive diseases and sciences,
C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori
July 1987, European journal of pediatrics,
C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori
July 1996, Gastroenterology,
C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori
July 2000, Immunology letters,
C Ferrari, and A Penna, and P Sansoni, and T Giuberti, and T M Neri, and F V Chisari, and F Fiaccadori
June 1978, The New England journal of medicine,
Copied contents to your clipboard!